id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-300038-1fjb6b8e	Cantini, Fabrizio	Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact	2020-04-23		.txt	text/plain	1264	57	41	On this basis, we assessed the safety of baricitinib therapy combined with lopinavir-ritonavir in moderate COVID-19 pneumonia patients and we evaluated its clinical impact. These results were likely due to the rapid action of the drug and the short median interval of 6 days from symptoms-onset and therapy starting, The major limitations of this pilot study were its open-label design with no randomization and the low number of treated patients.	cache/cord-300038-1fjb6b8e.txt	txt/cord-300038-1fjb6b8e.txt
